| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5391034 | Chemical Physics Letters | 2006 | 4 Pages |
Abstract
In this Letter, we report the three-photon absorption of hematoporphyrin IX (HpD-IX) in DMSO solution pumping at 1200Â nm with a 25Â ps pulse laser-OPG system. The obtained three-photon absorption cross-section in HpD-IX, Ï3â²=1.2Ã10-78cm6s2ph-2, is considerably high. Because HpD-IX is one of the main constituent of Photofrin® II, the only approved photodynamic therapy drug by the Food and Drug Association, this result is expected to have an impact in deep bioimaging and photodynamic therapy using currently available photosensitisers.
Related Topics
Physical Sciences and Engineering
Chemistry
Physical and Theoretical Chemistry
Authors
Ion Cohanoschi, Lorenzo EcheverrÃa, Florencio E. Hernández,